BOSTON & PARIS--(BUSINESS WIRE)--NMT Medical, Inc. (NASDAQ: NMTI) announced today at EuroPCR 2010 that it launched its RT2™ Delivery System, a pivotal breakthrough in septal implant delivery.
BOSTON & PARIS--(BUSINESS WIRE)--NMT Medical, Inc. (NASDAQ: NMTI) announced today at EuroPCR 2010 that it launched its RT2™ Delivery System, a pivotal breakthrough in septal implant delivery.